The related consequences of high levels of IL-22 have been fully illustrated in the diethylnitrosamin induced hepatocellular carcinoma model, where IL-22 transgenic mice show increased and IL–22-/- mice decreased tumor formation (115). This evidence concerns the gene IL22 and hepatocellular carcinoma.